Addiction最新文献

{"title":"Did the United States smokeless tobacco industry use cigarette industry strategies to sponsor and manipulate research?","authors":"David S Timberlake, Bryan D Nguyen, Andrew T Nguyen","doi":"10.1111/add.70039","DOIUrl":"https://doi.org/10.1111/add.70039","url":null,"abstract":"<p><strong>Background and aim: </strong>The cigarette industry in the United States (US) laid the foundation for sponsoring research to improve public relations and defend against product liability cases. Fewer threats of litigation facing the US smokeless tobacco (SLT) industry may have contributed to the sponsorship of independent research on SLT use and health outcomes. This study aimed to determine whether the SLT industry used cigarette industry strategies to manipulate research on health risks.</p><p><strong>Methods: </strong>Internal industry documents (e.g. letters, memos) from the 1970s through 1990s were accessed through the online Truth Tobacco Industry Documents Library at the University of California, San Francisco. A framework of tobacco industry strategies and criteria for evaluating sponsored research formed the basis for categorizing and synthesizing documents identified via snowball sampling (n = 177). Summaries of awarded projects in annual reports of the Smokeless Tobacco Research Council (STRC) were coded for content (n = 189, 1982-1997).</p><p><strong>Results: </strong>Guided by legal counsel, the SLT industry sponsored research to support its interest group position; advocated against research on tobacco-specific carcinogens such as N-nitrosonornicotine (NNN); heavily criticized a case-control study on oropharyngeal cancer; and relied on a cadre of grantees and STRC leadership to testify against SLT restrictions. The STRC awarded a high proportion of projects on nicotine (78/189), including use for therapy (e.g. Tourette's syndrome), but underfunded epidemiologic research (n = 3). However, the STRC awarded projects on extracts or constituents (e.g. NNN, n = 30) that may have implicated SLT's role in carcinogenesis.</p><p><strong>Conclusions: </strong>While the Smokeless Tobacco Research Council awarded some research that may have weakened the industry, the Council's imbalanced portfolio of projects and inextricable link to industry likely favored the interest group position. Thus, we cannot conclude that the smokeless tobacco industry sponsored research solely for scientific discovery. Greater independence of industry-sponsored research could be achieved by delegating scientific decision-making to scientists (not legal counsel), limiting governance to those unaffiliated with the industry sponsor and not relying on grantees to defend the interest group position.</p>","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143633198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Amphetamine use and mental health difficulties across adolescence and young adulthood: An integrative data analysis of four Australasian cohort studies.","authors":"Christopher J Greenwood, James Foulds, Rebecca McKetin, Stephanie R Aarsman, Delyse Hutchinson, Jessica Kerr, Jessica A Heerde, John W Toumbourou, Joseph M Boden, Tim Slade, Yvonne Bonomo, Primrose Letcher, Craig A Olsson","doi":"10.1111/add.70033","DOIUrl":"https://doi.org/10.1111/add.70033","url":null,"abstract":"<p><strong>Background and aims: </strong>The use of amphetamines (including amphetamine and methamphetamine) has been consistently associated with mental health difficulties; however, the direction of potential causal relationships has not yet been established. This study aimed to assess the direction relationships between illicit amphetamine use and mental health difficulties across adolescence and young adulthood.</p><p><strong>Design: </strong>Observational study of four population-level cohorts participating in the Monitoring Illicit Substance Use (MISUse) Consortium.</p><p><strong>Setting: </strong>Australia and New Zealand.</p><p><strong>Participants: </strong>A total of 7527 participants (51% female) were used: Christchurch Health and Development Study (n = 1056), Australian Temperament Project (n = 1644), Victorian Adolescent Health Cohort Study (n = 1943) and International Youth Development Study (n = 2884).</p><p><strong>Measurements: </strong>Assessments were used to derive binary indicators of amphetamine use (≥monthly) and mental health difficulties during both adolescence (age 10-17 years) and young adulthood (age 18-30 years).</p><p><strong>Findings: </strong>Associations were estimated as Risk Ratios (RRs) with 95% confidence internals (CIs) using G-computation procedures, while accounting for 15 potential confounding factors and interactions between exposure and both study cohort and participant sex. The risk of mental health difficulties in young adulthood was 21% greater (RR = 1.21, 95% CI = 1.04, 1.41) for those who reported monthly or more frequent amphetamine use in adolescence. The risk of monthly or higher amphetamine use in young adulthood was 19% greater (RR = 1.19, 95% CI = 0.99, 1.45) in those who reported mental health difficulties in adolescence. There was also some evidence to suggest that in males the strongest association was from amphetamine use to mental health difficulties (RR = 1.24, 95% CI = 0.95, 1.60), while in females the strongest association was from mental health difficulties to amphetamine use (RR = 1.33, 95% CI = 0.99, 1.78).</p><p><strong>Conclusions: </strong>There appears to be a bidirectional association between monthly or more frequent amphetamine use and mental health difficulties from adolescence to young adulthood.</p>","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143633193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Over a decade later and Addiction journal is still committed to publishing qualitative research.","authors":"Joanne Neale, Brian C Kelly, Jordan M Braciszewski, Joanna Kesten, Stephen Lankenau, Paula Mayock, Jennifer Merrill","doi":"10.1111/add.70047","DOIUrl":"https://doi.org/10.1111/add.70047","url":null,"abstract":"","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143622849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Decentering alcohol: Non-drug pleasure and reinforcement as an alternative target","authors":"Samuel F. Acuff,&nbsp;Justin C. Strickland","doi":"10.1111/add.70048","DOIUrl":"10.1111/add.70048","url":null,"abstract":"&lt;p&gt;The opinion and debate piece by Nicholls and Hunt [&lt;span&gt;1&lt;/span&gt;] stimulates an interesting discussion on the importance of pleasure in public health-oriented research on alcohol. We agree that pleasure is an important concept in understanding alcohol use as well as other substance use, and that public health discourse limits its own efficacy by focusing primarily on harm without acknowledging many of the benefits people report experiencing from drinking (or other drug use). This idea is broadly consistent with the behavioral science literature, which posits that alcohol can function as a positive reinforcer by producing desirable effects (e.g. enhancing social connection, inducing pleasant subjective effects) that increase the likelihood of future alcohol use.&lt;/p&gt;&lt;p&gt;These reinforcing effects may, at least during any discrete use occasion, outweigh the costs, acute or chronic, of alcohol use [&lt;span&gt;2&lt;/span&gt;]. Although humans are motivated by costly immediate harms [&lt;span&gt;3&lt;/span&gt;], they are less so by delayed, diffuse, and uncertain ones [&lt;span&gt;4-6&lt;/span&gt;]. This human aversion to immediate harms is matched by an innate, evolutionarily adaptive drive for pleasure or related positive subjective states. From a population perspective, harms associated with alcohol use are characteristically delayed, diffuse and uncertain for most people who use alcohol, if they experience problems at all, and rewards are often immediate and robust. In the case of social connection, for example, alcohol may help to facilitate a basic human need of social bonding [&lt;span&gt;7, 8&lt;/span&gt;] while only inconsistently resulting in harms that lessen this potent reward. Ignoring the reality that many find alcohol to be pleasurable goes against the experience of many who drink and threatens to delegitimize public health messaging. A similar problem can be found in many treatment settings that focus almost exclusively on reiterating harms of alcohol while failing to acknowledge that drinking once served an adaptive function, even if for most it was maladaptive by the time treatment began.&lt;/p&gt;&lt;p&gt;Although perhaps conspicuously absent from public health messaging research, there is a rich history of experimental work describing the pleasurable effects of alcohol and other drugs [&lt;span&gt;9-12&lt;/span&gt;]. These studies, typically conducted in the framework described by the United States Food and Drug Administration Human Abuse Potential guidelines, seek to evaluate subjective effects like ‘Good Effect’ or ‘Drug Liking’ and determine the potential for a drug's future misuse [&lt;span&gt;13&lt;/span&gt;]. Notably, these studies highlight the role that pleasure, or more broadly positive reinforcing effects, play in determining future behavior—behaviors that evoke greater pleasure are more likely to be repeated in the future, and a drug's ‘abuse potential’ is at least in part related to its ability to induce pleasure.&lt;/p&gt;&lt;p&gt;In addition to understanding the importance of the reinforcing efficacy of alcoho","PeriodicalId":109,"journal":{"name":"Addiction","volume":"120 6","pages":"1086-1087"},"PeriodicalIF":5.2,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.70048","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143622845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Taking pleasure seriously: Should alcohol research say more about fun? ‘No safe level’ advocates must take note","authors":"James Morris,&nbsp;Emma Davies","doi":"10.1111/add.70050","DOIUrl":"10.1111/add.70050","url":null,"abstract":"&lt;p&gt;Nicholls and Hunt propose three arguments for why pleasure should be taken more seriously in alcohol research and policy debates [&lt;span&gt;1&lt;/span&gt;]. We concur with each, but focus here on the pragmatic case; namely, that ignoring the experienced pleasures of drinking can undermine public health efforts towards reducing alcohol harm.&lt;/p&gt;&lt;p&gt;Nicholls and Hunt highlight the limitations of health messages for behaviour change, notably observing that a public health ‘expert story’ of alcohol being inherently dangerous ‘runs hard against a public view of drinking’ as generally positive. We believe this is particularly important for public health actors to attend to, especially considering the increasing focus on cancer risks and ‘no safe level of consumption’ messaging. Psychological research has explored a range of phenomena that can inform public health messaging in this regard.&lt;/p&gt;&lt;p&gt;In addition to the risk of failing to change behaviour, messages that run against people's lived experiences risk backfire effects [&lt;span&gt;2&lt;/span&gt;]. Even neutral alcohol risk messages have been found to evoke &lt;i&gt;defensive processing&lt;/i&gt; amongst heavier drinkers, provoking denial, minimization or the avoidance of content, below conscious awareness [&lt;span&gt;3&lt;/span&gt;]. This resistance appears to increase linearly with the level of consumption, indicating that the more individually relevant the risk information, the more likely that drinkers are to reject it [&lt;span&gt;3&lt;/span&gt;]. This is not to infer that risk-based messaging is redundant; rather, the mixed evidence on its effectiveness highlights the need for further understanding of the specific role of message content and key moderating processes, such as perceived relevance, emotional responses and self-efficacy [&lt;span&gt;3-5&lt;/span&gt;].&lt;/p&gt;&lt;p&gt;Qualitative research has also identified how heavier drinkers use personal exceptionalism and othering as strategies to construct and place their own drinking as ‘responsible’ in contrast to a stereotyped ‘other’ [&lt;span&gt;6&lt;/span&gt;], including in response to alcohol health warnings [&lt;span&gt;7&lt;/span&gt;]. Drinkers perceive a wide range of positives associated with drinking and are skilled at deploying these to resolve any dissonance invoked by incongruent information [&lt;span&gt;6-8&lt;/span&gt;]. An evolving literature highlights how framing, stigma and identity processes may be involved in rejecting messages that are incongruent with a drinker's own experiences of alcohol use as being largely without problems and pleasurable [&lt;span&gt;3, 4, 9, 10&lt;/span&gt;].&lt;/p&gt;&lt;p&gt;In addition to overlooking pleasure in drinking, ‘no safe level’ messaging may also reinforce the general perception that abstinence is the only acceptable goal. Indeed, abstinence can be perceived as threatening to drinkers and result in resistance or even the stigmatization of non-drinkers [&lt;span&gt;11&lt;/span&gt;]. Rather, it has been argued that an increasing recognition of moderation as an acceptable goal has a number of public health benefits [&lt;span&gt;12&lt;/span","PeriodicalId":109,"journal":{"name":"Addiction","volume":"120 6","pages":"1084-1085"},"PeriodicalIF":5.2,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.70050","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143622850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Medication experiences in the treatment of opioid use disorders: Insights from Reddit.","authors":"Alexandra Almeida, Mike Conway, David J Grelotti, Amarnath Gupta, David Frank, Annick Bórquez","doi":"10.1111/add.70022","DOIUrl":"https://doi.org/10.1111/add.70022","url":null,"abstract":"<p><strong>Background and aims: </strong>Better understanding the challenges faced by patients on medications for opioid use disorder (MOUD), including methadone and buprenorphine, is critical to increasing their use/retention. Social media platforms such as Reddit offer a space for patients to share their experiences with medications. We aimed to identify and characterize challenges faced by patients taking MOUD through analysis of discussions from the r/Methadone and r/suboxone subreddits.</p><p><strong>Design, setting and participants: </strong>Mixed methods study applying natural language processing methods to 37 278 posts from both subreddits from their origin in 2011 until 31 December 2022. Independent topic analyses used Correlated Topic Models to extract the main themes discussed.</p><p><strong>Measurements: </strong>We labeled, validated and grouped the topics into macro classes and computed topic shares. We interpreted and compared topics across subreddits informed by the patient-centered medication experience framework.</p><p><strong>Findings: </strong>We found 27 and 34 challenge-related topics for the r/Methadone and r/suboxone subreddits, respectively. Topics were grouped into three macro-topics: (i) healthcare-related issues, including misunderstandings/confusion around appointments, prescriptions, bottle checks, telehealth technology and health insurance coverage; (ii) medication-related issues, including withdrawal, cravings, dosage, side effects, mixing with other medications/drugs; and (iii) treatment discontinuation, including tapering protocols. Patients conveyed highly specialized knowledge about dosage and tapering strategies and spoke from experience. Key differences between r/Methadone and r/suboxone were driven by their dispensing requirements (clinic-based vs. take-home), with 20.05% vs 14.74% of posts related to healthcare service, primarily for logistic and interpersonal issues with healthcare providers.</p><p><strong>Conclusion: </strong>People who post on the r/Methadone and r/suboxone subreddits appear to have detailed knowledge of medications for opioid use disorder and want more control over their dosing, effects, side effects and discontinuation. Acknowledging this expertise and establishing stronger patients' partnerships with the healthcare team and system might result in better treatment outcomes.</p>","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143612774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Identifying hazardous alcohol use in primary care using phosphatidylethanol: Timing of screening matters.","authors":"Viktor Månsson, Maria Hårdstedt, Anders Hammarberg, Anders Hake, Riccardo LoMartire","doi":"10.1111/add.70036","DOIUrl":"https://doi.org/10.1111/add.70036","url":null,"abstract":"<p><strong>Background and aims: </strong>Alcohol is a well-established risk factor for numerous health conditions, making screening for hazardous alcohol use in healthcare a critical task. While self-reported data suggest that alcohol consumption varies across seasons, this seasonal fluctuation has not yet been confirmed using objective biological markers. This study aimed to measure whether phosphatidylethanol (PEth) captures variations in hazardous alcohol use across two temporal resolutions: month of the year and day of the week.</p><p><strong>Design: </strong>Observational cross-sectional study based on data from medical records.</p><p><strong>Setting: </strong>Healthcare services, Region Dalarna, Sweden, between 2017 and 2023.</p><p><strong>Participants/cases: </strong>Adult patients (n = 62 431, 50% females) screened for hazardous alcohol use with PEth within primary care.</p><p><strong>Measurements: </strong>This study utilizes test results from PEth, with results >0.30 μmol/l defined as hazardous alcohol use. We compared the prevalence of hazardous alcohol use across months and weekdays using logistic regression while adjusting for sex, age, smoking status, the Charlson Comorbidity Index and psychiatric diagnoses.</p><p><strong>Findings: </strong>The prevalence of hazardous alcohol use increased between May and August, ranging from 13.2% to 15.9%, compared with 10.7% in November. This corresponds to a 48% relative increase in the peak month of July [prevalence ratio (PR) = 1.48, 95% confidence interval (CI) = 1.33-1.64]. Hazardous alcohol use was also more prevalent among patients tested on Mondays (13.0%) compared with Thursdays, with the lowest prevalence (12.0%). The difference was particularly pronounced among female patients, with a 14.0% higher relative prevalence on Mondays (PR = 1.14, 95% CI = 1.02-1.27).</p><p><strong>Conclusions: </strong>In Sweden, the prevalence of hazardous alcohol use appears to fluctuate seasonally and, to a lesser extent, across weekdays, as measured by blood tests for phosphatidylethanol, a biomarker for hazardous alcohol use. November showed the lowest prevalence and July the highest, consistent across age, sex and the year of the observational period. Hazardous alcohol use showed a slight elevation of prevalence during Mondays compared with Tuesday to Friday.</p>","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143622847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"intEgrating Smoking Cessation treatment As part of usual Psychological care for dEpression and anxiety (ESCAPE): A randomised and controlled, multi-centre, acceptability and feasibility trial with nested qualitative methods","authors":"Gemma M. J. Taylor,&nbsp;Katherine Sawyer,&nbsp;Pamela Jacobsen,&nbsp;Tom P. Freeman,&nbsp;Anna Blackwell,&nbsp;Shadi Daryan,&nbsp;Chris Metcalfe,&nbsp;David Kessler,&nbsp;Marcus R. Munafò,&nbsp;Paul Aveyard","doi":"10.1111/add.16718","DOIUrl":"10.1111/add.16718","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Background and aim&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;There is evidence that smoking cessation may improve depression and anxiety symptoms. We assessed the feasibility of implementing and trialling a smoking cessation intervention in services providing cognitive behavioural therapy (CBT) for common mental illness.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Design, setting and participants&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;This study was a pragmatic, two-armed, randomised, multi-centre, acceptability and feasibility trial of a co-designed smoking cessation intervention (ISRCTN99531779) involving United Kingdom National Health Service (NHS)-funded services treating depression or anxiety among four NHS Trusts. Participants comprised adult daily smokers starting CBT for depression or anxiety [mean age 35.6 years, standard deviation (SD) = 12.7, 89.6% white] who smoked 14.3 (SD = 8.2) cigarettes/day with mean Generalised Anxiety Disorder Questionnaire-7 (GAD-7) and Patient Health Questionnaire-9 (PHQ-9) scores of 13.1 (SD = 4.9) and 14.5 (SD = 6.0). Sixty-eight participants were allocated to the treatment group and 67 to control.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Intervention and control&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Both groups received CBT for depression or anxiety. The treatment group also received up to 12 sessions of integrated smoking cessation support. The control group was signposted to smoking cessation services post-treatment.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Measurements&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Follow-up was at 3 and 6 months. The primary outcome was ‘study completion’ by 3 months. Other outcomes included acceptability, satisfaction, feasibility, data completeness and mental health.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Findings&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;At 3 months, treatment did not affect study completion [odds ratio (OR) = 0.81, 95% confidence interval (CI) = 0.31 to 2.09], did not harm mental health (PHQ-9 difference: coefficient 0.01, 95% CI = −2.19 to 2.22); GAD-7: coefficient 0.65, 95% CI = −1.59 to 2.90), but increased abstinence rates (OR = 8.69, 95% CI = 1.11 to 396.26). Recruitment was acceptable and key stakeholders were satisfied with the intervention.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Among UK adult smokers receiving CBT treatment for depression or anxiety, a smoking cessation intervention within the CBT treatment was well received, did not interfere with the primary treatment goals and increased smoking cessation.&lt;/p&gt;\u0000 ","PeriodicalId":109,"journal":{"name":"Addiction","volume":"120 5","pages":"922-936"},"PeriodicalIF":5.2,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.16718","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143603262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Let's talk about pleasure: Bridging the sociology and public health divide","authors":"Amy Pennay,&nbsp;Michael Livingston","doi":"10.1111/add.70035","DOIUrl":"10.1111/add.70035","url":null,"abstract":"&lt;p&gt;The recent article by Nicholls and Hunt [&lt;span&gt;1&lt;/span&gt;] is an insightful take on a long-existing problem, and, if heeded, has the potential to progress public health research forward in a meaningful way. As Nicholls and Hunt point out, sociology has long effectively engaged with the concept of pleasure relating to alcohol use, although public health and epidemiological approaches have rarely acknowledged it. Sociological research clearly shows that pleasure—including, but not restricted to social, emotional and sensorial pleasure—is key to decisions around drinking, and this is true even for those who know of the health risks of alcohol use [&lt;span&gt;2-5&lt;/span&gt;]. Consequently, treating long-term health as more important than shorter-term pleasures is not justifiable. As David Lynch recently said of his smoking, which ultimately took his life in 2025, ‘I don't regret it. It was important to me’ [&lt;span&gt;6&lt;/span&gt;]. The cost–benefit analyses of drinkers are well established in a similar way.&lt;/p&gt;&lt;p&gt;As Nicholls and Hunt note, economists have made the most concrete efforts to bridge the divide between sociology and public health, focusing on utility or consumer benefits to try to account for the positive impacts of drinking on consumers' lives [&lt;span&gt;7&lt;/span&gt;]. These efforts often, although famously not always [&lt;span&gt;8&lt;/span&gt;], use complex formulae or bold assumptions to discount the benefits of heavy consumption because they reflect the ‘irrational’ preferences of dependent or intoxicated drinkers [&lt;span&gt;9&lt;/span&gt;]. These approaches, alongside the substantial sociological research on pleasure, have had only minimal impact on public health.&lt;/p&gt;&lt;p&gt;To sociologists, the lack of attention to social and mental wellbeing in public health research on alcohol in issues - such as calculating the cost of alcohol to society or developing drinking guidelines - is hard to understand because it does not speak to the data. It ignores the lived experience of drinkers who make decisions based on many factors, only one of those being health [&lt;span&gt;2, 5, 10&lt;/span&gt;]. It is time for sociology and public health to work together on this topic rather than remain at odds around the issue of pleasure in alcohol research. In our experience, sociologists and public health researchers have either tended to ignore each others' research or, even more unhelpfully, actively attempted to contest it. This hinders meaningful progress on the topic of pleasure in public health research because insights from interdisciplinary research on alcohol and pleasure have the potential to take public health research in important new directions.&lt;/p&gt;&lt;p&gt;We believe that sociology, epidemiology and public health must work together in an interdisciplinary fashion on alcohol-related pleasure. Understanding how drinkers think about pleasure and health, how each is prioritised, how drinkers understand and trade-off short and long-term benefits and consequences, what types and levels of risk are deemed acceptab","PeriodicalId":109,"journal":{"name":"Addiction","volume":"120 6","pages":"1082-1083"},"PeriodicalIF":5.2,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.70035","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143595885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Commentary on Day et al.: From concept to practice-Challenges in building a continuum of recovery support services in Belgium.","authors":"Wouter Vanderplasschen, Florian De Meyer, Clara De Ruysscher","doi":"10.1111/add.70020","DOIUrl":"https://doi.org/10.1111/add.70020","url":null,"abstract":"","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143565655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}